Prostate cancer metastatic to the external auditory canals

被引:6
|
作者
Shrivastava, Vikas
Christensen, Rebecca
Poggi, Matthew M.
机构
[1] Natl Naval Med Ctr, Div Radiat Oncol, Bethesda, MD 20889 USA
[2] Natl Naval Med Ctr, Dept Pathol, Bethesda, MD 20889 USA
[3] Uniformed Serv Univ Hlth Sci, Dept Radiol, Bethesda, MD 20814 USA
关键词
adenocarcinoma; antiandrogen therapy; prostate-specific antigen;
D O I
10.3816/CGC.2007.n.015
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A 58-year-old white man with prostate-specific antigen (PSA) level of 6 ng/mL, a Gleason score of 6 (3+3), T2a adenocarcinoma of the prostate underwent prostatectomy. On review of the pathology, the specimen contained a Gleason score of 8 (3+5) with other high-risk features. The patient had a persistently elevated postoperative PSA level and was placed on total androgen blockade. The PSA continued to increase, and the patient developed bone-only metastatic disease. The patient was treated with palliative external-beam radiation and samarium. Six months later, he presented with bilateral hearing loss and was found to have pathologic and radiographic evidence of metastatic prostate cancer to the external auditory canals. This was an unusual late finding. The patient died shortly afterward before completing palliative treatment to the area.
引用
收藏
页码:341 / 343
页数:3
相关论文
共 50 条
  • [41] Characteristics of metastatic prostate cancer
    Che, M
    Singh, RS
    Sakr, W
    Grignon, D
    MODERN PATHOLOGY, 2005, 18 : 132A - 132A
  • [42] Abiraterone in Metastatic Prostate Cancer
    Tannock, Ian F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (17): : 1695 - 1695
  • [43] Management of metastatic prostate cancer
    Rosenthal, MA
    MEDICAL JOURNAL OF AUSTRALIA, 1998, 169 (01) : 46 - 50
  • [44] Metastatic prostate cancer: Treatments
    Descotes, J. -L.
    Cadi, P.
    Long, J. -A.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2008, 32 (01): : 51 - 56
  • [45] Prostate cancer metastatic to the omentum
    Kehinde, EO
    Abdeen, SM
    Al-Hunayan, A
    Ali, Y
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2002, 36 (03): : 225 - 227
  • [46] MELPHALAN IN METASTATIC CANCER OF THE PROSTATE
    FRANKS, CR
    CANCER TREATMENT REVIEWS, 1979, 6 : 121 - 125
  • [47] Cabazitaxel in Metastatic Prostate Cancer
    de Wit, Ronald
    de Bono, Johann
    Castellano, Daniel
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (13): : 1286 - 1286
  • [48] Stakes in the metastatic prostate cancer
    Rossi, D.
    Mourey, L.
    Mottet, N.
    Crehange, G.
    Loriot, Y.
    Latorzeff, I.
    Audenet, F.
    PROGRES EN UROLOGIE, 2015, 25 : S10 - S15
  • [49] HYPOPHYSECTOMY IN METASTATIC PROSTATE CANCER
    THOMPSON, JB
    GREENBERG, E
    PAZIANOS, A
    PEARSON, OH
    NEW YORK STATE JOURNAL OF MEDICINE, 1974, 74 (06) : 1006 - 1008
  • [50] The management of metastatic prostate cancer
    Turner, Bruce
    Drudge-Coates, Lawrence
    INTERNATIONAL JOURNAL OF UROLOGICAL NURSING, 2009, 3 (03) : 93 - 103